Nishimura F, Oniki K, Yamashita A, Honda K, Kawata K, Ushijima T, Hamada S, Miyamura S, Saruwatari J.
Prognostic role of intramuscular adipose tissue content in patients with urothelial carcinoma treated with pembrolizumab.
Int Urol Nephrol. 2025 Online ahead of print.

Kajiwara-Morita A, Oniki K, Yoshida A, Kurinami N, Suzuki T, Miyamoto F, Hieshima K, Sugiyama S, Kajiwara K, Jinnouchi K, Saruwatari J, Jinnouchi H.
Impact of Albuminuria and Renal Dysfunction on the Anemia-Improving Effect of SGLT2 Inhibitors in Patients With Type 2 Diabetes: A Real-World Observational Study.
J Diabetes Res. 2025;2025:5399360.

Shigetome K, Egashira T, Tomita T, Higa N, Iwashita K, Morita K, Nishimura M, Kaneko T, Maeda H, Yamada KD, Kajiwara-Morita A, Oniki K, Yasui-Furukori N, Saruwatari J.
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic-Pharmacodynamic and Machine Learning Analyses.
CPT Pharmacometrics Syst Pharmacol. 2025;14(6):1119-1127.

Fukuda R, Fujiwara Y, Maeda H, Pan C, Minayoshi Y, Yano H, Mizuta Y, Takano M, Yamada R, Saito Y, Hirata K, Imoto S, Yamasaki K, Oniki K, Saruwatari J, Otagiri M, Watanabe H, Komohara Y, Maruyama T.
Lymph node macrophage-targeted interferon alpha boosts anticancer immune responses by regulating CD169-positive phenotype of macrophages.
Mol Cancer. 2025;24(1):132.

Oniki K, Shigaki T, Kajiwara-Morita A, Shigetome K, Yoshida A, Jinnouchi H, Saruwatari J.
Quantitative assessment of metabolic memory and its prediction of renal function decline in patients with type 2 diabetes: A retrospective observational study
Diabetes Metab Syndr. 2025;19(4):103225.

Sugiura A, Makise K, Narita Y, Nakata E, Matushita K, Oda K, Saruwatari J, Jono H, Nishi K, Saito H.
Validation of the Utility of the Uremic Toxin Integrated Score as a Prognostic Factor for Cardiovascular Complications in Hemodialysis Patients: A Pilot Study.
BPB Reports. 2025;8(6):157-163.

Yamamoto M, Yamamoto K, Takano-Ohmuro K, Yamamoto R, Saruwatari J.
Usability Evaluation of Foods with Function Claims Labelling as Health Information in Japan: A User-Testing Study.
NUTRITION AND DIETARY SUPPLEMENTS. 2025;17:1-18.

Mitsuboshi S, Hitoshi K, Ominato A, Kinoshita T, Sugimoto Y, Kajiwara-Morita A, Urata M, Sato K, Sakamaki T.
Association between sodium-glucose cotransporter-2 inhibitor and adverse events in patients with moderate to severe chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.
Eur J Clin Pharmacol. 2025;81(2):217-225.

Higashi-Kuwata N, Bulut H, Hayashi H, Tsuji K, Ogata-Aoki H, Kiso M, Takamune N, Kishimoto N, Hattori SI, Ishii T, Kobayakawa T, Nakano K, Shimizu Y, Das D, Saruwatari J, Hasegawa K, Murayama K, Sukenaga Y, Takamatsu Y, Yoshimura K, Aoki M, Furusawa Y, Okamura T, Yamayoshi S, Kawaoka Y, Misumi S, Tamamura H, Mitsuya H.
An orally available P1'-5-fluorinated Mpro inhibitor blocks SARS-CoV-2 replication without booster and exhibits high genetic barrier.
PNAS Nexus. 2025;4(1):578.

Hoshiyama T, Ashikaga K, Morihisa K, Ito M, Oniki K, Saruwatari J, Ishii M, Kanazawa H, Sumi H, Kaneko S, Kiyama T, Tsuruta Y, Matsunaga K, Tsurusaki Y, Tsujita K.
Association Between ALDH2 Genotypes and Atrial Fibrillation Recurrence Following Catheter Ablation: Prospective Multicenter Cohort Study.
Circ Arrhythm Electrophysiol. 2025;18(1):e013433

長谷川 浩三, 森山 健一, 岡本 茂洋, 羽山 悦子, 玉飼 博之, 鬼木 健太郎, 猿渡 淳二, 門脇 大介
心不全シールの導入前後での外来心不全患者の服薬状況と体調管理についての実態調査
医療薬学 2025;51(5):307-317.

成瀬 遥佳, 守田 彩文, 三宅 俊介, 守田 和憲, 金子 哲也, 鬼木 健太郎, 猿渡 淳二, 城野 博史
がん薬物療法での漢方薬の臨床使用実態調査と化学療法誘発性末梢神経障害に対する牛車腎気丸の有効性検討への応用
医療薬学 2025;51(4):218-225.